Endo tops Wall Street quarterly estimates

July 31 (Reuters) - Specialty healthcare company Endo International Plc reported a better-than-expected quarterly profit, helped by a 60 percent rise in U.S. generic sales, and it raised its full-year forecast.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.